IONS
Ionis Pharmaceuticals, Inc. · Healthcare
EVP Research Eric Swayze sold $1.3M of Ionis Pharmaceuticals, Inc.
Sold$1,278,914
$81.76Price
15,642Shares
−33%Stake
What IONS did after the filing
- The stock from Fri, Feb 13 close, $80.60
- −10.0%
- S&P 500, same days
- −7.3%
Measured over 30 trading days, to the Mar 30 close.
Traded Fri, Feb 13. Filed Fri, Feb 13, 2:40 PM ET, during the session. Returns use the Feb 13 close and the Mar 30 close. Not investment advice.